Analysis of the growth characteristics of a primary BALB/c IgG plasmacytoma
暂无分享,去创建一个
[1] B. Dieckgraefe,et al. Lymphocyte surface membrane immunoglobulin in myeloma. III. IgA plasmacytomas induce large numbers of circulating, adult-thymectomy-sensitive, theta +, Lyt-1-2+ lymphocytes with IgA-Fc receptors. , 1982, Journal of immunology.
[2] H. Haubeck,et al. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis. , 1982, Immunology.
[3] B. Loveland,et al. Which T cells cause graft rejection , 1982 .
[4] V. Schirrmacher,et al. High‐frequency generation of new immunoresistant tumor variants during metastasis of a cloned murine tumor line (ESb) , 1982, International journal of cancer.
[5] A. Abbas,et al. Immunologic regulation of lymphoid tumor cells: model systems for lymphocyte function. , 1982, Advances in immunology.
[6] M. Cohn,et al. Tumorigenicity and lysis by natural killers , 1981, The Journal of experimental medicine.
[7] B. Odermatt,et al. Immunoregulation of Murine Myeloma Cell Growth and Differentiation; A Monoclonal Model of B Cell Differentiation 1 , 1979, Immunological reviews.
[8] C. Frondoza,et al. Temporary disappearance ("eclipse") of LPC-1 plasmacytoma M component synthesis following tumor cell transfer. , 1979, Cancer Research.
[9] B. Odermatt,et al. Immunoregulation of murine myeloma: isologous immunization with M315 induces idiotype-specific T cells that suppress IgA secretion by MOPC-315 cells in vivo. , 1979, Journal of immunology.
[10] C. Jenkin,et al. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. , 1978, Immunochemistry.
[11] R. Burton,et al. Tumor immunity to murine plasma cell tumors. V. Demonstration of a unique tumor antigen that is not associated with the myeloma idiotype , 1978, International journal of cancer.
[12] J. Russell,et al. Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Lynch,et al. Specific, immunologic regulation of differentiation of immunoglobulin expression in MOPC-315 cells during in vivo growth in diffusion chambers. , 1977, Journal of immunology.
[14] R. Lynch,et al. Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation. , 1977, Journal of immunology.
[15] R. Lynch,et al. Myeloma-specific antibodies: studies of their properties and their relationship to tumor immunity. , 1977, Journal of immunology.
[16] G. Klein,et al. Rejectability of virus-induced tumors and nonrejectability of spontaneous tumors: a lesson in contrasts. , 1977, Transplantation proceedings.
[17] H. Hewitt,et al. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. , 1976, British Journal of Cancer.
[18] I. Witz,et al. PROTECTIVE AND CELLULAR IMMUNE RESPONSES TO IDIOTYPIC DETERMINANTS ON CELLS FROM A SPONTANEOUS LYMPHOMA OF NZB/NZW F1 MICE , 1974, The Journal of experimental medicine.
[19] J. Schrader,et al. EFFECTOR CELL BLOCKADE A NEW MECHANISM OF IMMUNE HYPOREACTIVITY INDUCED BY MULTIVALENT ANTIGENS , 1974 .
[20] P. Johnson,et al. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation. , 1972, Journal of the National Cancer Institute.
[21] M. Potter. Immunoglobulin-producing tumors and myeloma proteins of mice. , 1972, Physiological reviews.
[22] H. Eisen,et al. Myeloma proteins as tumor-specific transplantation antigens. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Prehn. The Immune Reaction as a Stimulator of Tumor Growth , 1972, Science.
[24] T. Kindt,et al. THE INHERITANCE OF INDIVIDUAL ANTIGENIC SPECIFICITIES OF RABBIT ANTIBODIES TO STREPTOCOCCAL CARBOHYDRATES , 1971, Journal of Experimental Medicine.
[25] E. Kölsch. An alteration of secreted immunoglobulin in serum. , 1967, Journal of immunology.